UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach

Journal of neural transmission. Supplementum, 2007 (72), p.217-233

2007

Volltextzugriff (PDF)

Changes in cytokines and neurotrophins in Parkinson's disease

Journal of neural transmission. Supplementum, 2000 (60), p.277

2000

Volltextzugriff (PDF)

Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein

Journal of neural transmission. Supplementum, 2007 (72), p.195-202

2007

Volltextzugriff (PDF)

The discovery of dopamine deficiency in the parkinsonian brain

Journal of neural transmission. Supplementum, 2006 (70), p.9-15

2006

Volltextzugriff (PDF)

Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease

Journal of neural transmission. Supplementum, 2006 (70), p.177-180

2006

Volltextzugriff (PDF)

Impaired iron homeostasis in Parkinson's disease

Journal of neural transmission. Supplementum, 2000 (60), p.37

2000

Volltextzugriff (PDF)

Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease

Journal of neural transmission. Supplementum, 2006 (70), p.99-103

2006

Volltextzugriff (PDF)

Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?

Journal of neural transmission. Supplementum, 2002 (62), p.241

2002

Volltextzugriff (PDF)

Mechanism of 6-hydroxydopamine neurotoxicity

Journal of neural transmission. Supplementum, 1997, Vol.50, p.55

1997

Volltextzugriff (PDF)

Pathology associated with sporadic Parkinson’s disease — where does it end?

Journal of neural transmission. Supplementum, 2006 (70), p.89-97

2006

Volltextzugriff (PDF)

Neurosurgery in Parkinson’s disease: the doctor is happy, the patient less so?

Journal of neural transmission. Supplementum, 2006 (70), p.409-414

2006

Volltextzugriff (PDF)

Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects

Journal of neural transmission. Supplementum, 2007 (72), p.113-120

2007

Volltextzugriff (PDF)

Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus

Journal of neural transmission. Supplementum, 2007 (72), p.235-240

2007

Volltextzugriff (PDF)

Deep brain stimulation for the treatment of Parkinson’s disease

Journal of neural transmission. Supplementum, 2006 (70), p.393-399

2006

Volltextzugriff (PDF)

GDF-15/MIC-1 a novel member of the TGF-beta superfamily

Journal of neural transmission. Supplementum, 2000 (60), p.273

2000

Volltextzugriff (PDF)

Basic mechanisms of brain inflammation

Journal of neural transmission. Supplementum, 1997, Vol.50, p.183

Lassmann, H

1997

Volltextzugriff (PDF)

Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats

Journal of neural transmission. Supplementum, 1998, Vol.53, p.299

1998

Volltextzugriff (PDF)

Potential sources of increased iron in the substantia nigra of parkinsonian patients

Journal of neural transmission. Supplementum, 2006 (70), p.133-142

2006

Volltextzugriff (PDF)

Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway

Journal of neural transmission. Supplementum, 2000 (60), p.261

2000

Volltextzugriff (PDF)

Vascular-ischemic dementia: an update

Journal of neural transmission. Supplementum, 2002 (62), p.1

Jellinger, K A

2002

Volltextzugriff (PDF)

Animal models of Parkinson's disease in rodents induced by toxins: an update

Journal of neural transmission. Supplementum, 2003 (65), p.89

2003

Volltextzugriff (PDF)

Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease

Journal of neural transmission. Supplementum, 2003 (67), p.149

2003

Volltextzugriff (PDF)

M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson’s disease

Journal of neural transmission. Supplementum, 2006 (70), p.447-456

2006

Volltextzugriff (PDF)

Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling

Journal of neural transmission. Supplementum, 2000 (60), p.77

2000

Volltextzugriff (PDF)

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view

Journal of neural transmission. Supplementum, 2007 (72), p.269-280

2007

Volltextzugriff (PDF)

1 – 25 von 274

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAdvances In Neurobiology

SpracheJapanisch

KollektionEbook Central Perpetual and DDA

Zeitschrift / SerieJournal Of Neural Transmission. Supplementum

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(274)

Sprache

Englisch
(274)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach

Changes in cytokines and neurotrophins in Parkinson's disease

Long-term abnormalities in brain glucose/energy metabolism after inhibition of the neuronal insulin receptor: implication of tau-protein

The discovery of dopamine deficiency in the parkinsonian brain

Nicotine induces brain CYP enzymes: relevance to Parkinson’s disease

Impaired iron homeostasis in Parkinson's disease

Critical appraisal of brain pathology staging related to presymptomatic and symptomatic cases of sporadic Parkinson’s disease

Neurotrophic factors and Alzheimer's disease: are we focusing on the wrong molecule?

Mechanism of 6-hydroxydopamine neurotoxicity

Pathology associated with sporadic Parkinson’s disease — where does it end?

Neurosurgery in Parkinson’s disease: the doctor is happy, the patient less so?

Biochemistry of postmortem brains in Parkinson’s disease: historical overview and future prospects

Brain antioxidant capacity in rat models of betacytotoxic-induced experimental sporadic Alzheimer’s disease and diabetes mellitus

Deep brain stimulation for the treatment of Parkinson’s disease

GDF-15/MIC-1 a novel member of the TGF-beta superfamily

Basic mechanisms of brain inflammation

Brain-derived peptides reduce the size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats

Potential sources of increased iron in the substantia nigra of parkinsonian patients

Insulin-like growth factor-1 (IGF-1): a neuroprotective trophic factor acting via the Akt kinase pathway

Vascular-ischemic dementia: an update

Animal models of Parkinson's disease in rodents induced by toxins: an update

Cytoskeleton derangement in brain of patients with Down syndrome, Alzheimer's disease and Pick's disease

M30, a novel multifunctional neuroprotective drug with potent iron chelating and brain selective monoamine oxidase-ab inhibitory activity for Parkinson’s disease

Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling

The immunological basis of glutamatergic disturbance in schizophrenia: towards an integrated view

Aktive Filter

Suchergebnisse filtern